|
|
Volumn 11, Issue 4, 2000, Pages 345-349
|
|
Lipid-lowering drug therapy: More knowledge leads to more problems for composers of guidelines
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTILIPEMIC AGENT;
CHOLESTEROL;
FIBRIC ACID DERIVATIVE;
GEMFIBROZIL;
SIMVASTATIN;
STATIN;
TRIACYLGLYCEROL;
BLOOD PRESSURE;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
HUMAN;
ISCHEMIC HEART DISEASE;
META ANALYSIS;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
REVIEW;
RISK FACTOR;
ANTILIPEMIC AGENTS;
CORONARY DISEASE;
FEMALE;
HUMANS;
HYPERLIPIDEMIAS;
LINEAR MODELS;
MALE;
RISK FACTORS;
SEX FACTORS;
|
|
EID: 0033862240
PISSN: 09579672
EISSN: None
Source Type: Journal
DOI: 10.1097/00041433-200008000-00001 Document Type: Review |
|
Times cited : (9)
|
|
References (38)
|
